Assessment of blood pressure in the population with impaired glucose tolerance in Bangladesh

Paper Details

Research Paper 01/07/2016
Views (170) Download (2)

Assessment of blood pressure in the population with impaired glucose tolerance in Bangladesh

Md. Monwarul Haque, M. Shahjahan, Md. Shahidul Haque, Md. Maniruzzaman, Khadiza Khanam, Nurul Absar
Int. J. Biosci.9( 1), 106-116, July 2016.
Certificate: IJB 2016 [Generate Certificate]


The regulation of blood pressure in population with IGT is a substantial issue although not characterized well. Therefore, the purpose of the present study is to clarify the role of dietary modification and physical exercise in subjects with impaired glucose tolerance on the regulation of cardiovascular homeostasis. Thirty three newly detected otherwise healthy subjects aged 35-63 years, were randomly selected to participate in a 12 weeks diet and exercise program and blood pressure was monitored and recorded from each participants. Mean systolic B.P (mm Hg) was recorded 118.83 ± 3.3 at base line with a range of 85-160 mm Hg. At the end of 12 weeks, systolic B.P. 117.36 ± 2.84 was demonstrated by the total group. Diastolic B.P was reduced significantly from 84.23 ± 2.33 at base line to 80.4 ± 2.07 mm Hg at follow-up. For men, both systolic and diastolic B.P were 116.87  4.78 and 84.06  3.71 at base line while 114.68  2.9 and 82.62  2.35 were recorded for follow-up respectively. For women, systolic and diastolic B.P were 121.07  4.6 and 84.42  2.79 at baseline and 120.42  5.11 and 77.85  3.5 at follow up respectively. In 35-40, 41-50 and 51-63 years group, the systolic pressures were recorded; similarly, the diastolic pressures for the respective groups were also monitored at baseline and follow-up. In different BMI groups, 118.5  6.14 vs. 114.5  3.76 (BMI 20-25) and 119.0  4.0 vs. 118.8  3.85 (BMI >25) systolic pressures were observed while 85.5  4.91 vs. 81.0  3.4 (BMI 20-25) and 83.6  2.58 vs. 80.1  2.66 (BMI >25) diastolic pressures for baseline and follow-up populations were demonstrated respectively. Although a significant role on lowering of diastolic pressure for individuals including women and middle aged people was noted however other groups were remained to be unchanged. The results would give a new insight on the characterization of IGT and the programme may play the critical role in this respect.


Anan F, Yonemochi H, Masaki T, Takahashi N, Fukunaga N, Teshima Y, Iwao T, Kaneda K, Eshima N, Saikawa T, Yoshimatsu H. 2007. High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertension Research 30, 125-131.

Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. 2000. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 23, 465-471.

Christ M, Klima T, Maisch B. 2003.  Artarial hypertension and metabolic syndrome. Herz 28, 674-685.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ. 2003. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289, 2560-2571.

Falkner B, Sherif K, Sumner AE,Kushner H. 1999. Blood pressure increase with impaired glucose tolerance in young adult American Blacks. Hypertension 34, 1086-1090.

Hansson G. 2005. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine 352, 1685-1695.

Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Rosett JW. 2009. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation 120, 1011-1020.

Koivisto VA, Yki-Jarvinen H, DeFronzo RA. 1986. Physical training and insulin sensitivity. Diabetes Metabolism Reviews 1, 445-81.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. 2002. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913.

Mahroos  FA,  Roomia  KA,  McKeigueb  PM. 2000. Relation of high blood pressure to glucoseintolerance, plasma lipids and educationalstatus in an Arabian Gulf population. International Journal of Epidemiology 29, 71-76.

Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. 1985. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. Journal of Clinical Investigation 75, 809-17.

Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. 2004. American College of Sports Medicine position stand. Exercise and hypertension. Medicine & Science in Sports & Exercise 36, 533-553.

Rao SS, Disraeli P, Mcgregor T. 2004. Impaired glucose tolerance and impaired fasting glucose. American Family Physician 69(8), 1961-1968.

Reitman JS, Vasquez B, Klimes I, Nagulesparan M. 1984. Improvement of glucose homeostasis after exercise training in non insulin dependent diabetes. Diabetes Care 7, 434-441.

Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. 2004. Insulin resistance and hypertension: the Insulin resistance atherosclerosis study. Hypertension 43, 1324-1331.

Schnell O, Standl E. 2006. Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocrine Practice 12(1), 16-19.

Schneider SH, Amorosa LF, Khachadurian AK, Ruderman NB. 1984. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin dependent diabetes). Diabetologia 26, 355-60.

Shinzato T, Ohya Y, Nakamoto M, Ishida A, Takishita S. 2007. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertension Research 30, 863-873.

Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Bennett PH. 1988. The natural history of impaired glucose tolerance in the Pima Indians. New England Journal of Medicine 319, 1500-1506.

Savage PJ, Bennion LJ, Flock EV, Nagulesparan M, Mott D, Roth J, Unger RH, Bennett PH. 1979. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 48, 999-1007.

Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. 1999. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not in impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22, 920-924.

Tsai PS, Ke TL, Huang CJ,Tsai JC, Chen PL, Wang SY,Shyu YK. 2005. Prevalence and determinants of prehypertension status in the Taiwanese general population. Journal of Hypertension 23, 1355-1360. c3

Trinder P. 1969. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Annals of Clinical Biochemistry 6, 24-27.

Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. 2001. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358, 1682-1686.

Zhang Y, Lee ET, Devereux RB,Yeh J, Best LG, Fabsitz RR, Howard BV. 2006. Prehypertension, diabetes, and cardiovascular disease risk in a population based sample: the Strong Heart Study. Hypertension 47, 410-414.